| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |